UHealth – the University of Miami Health System, the University of Miami Leonard M. Miller School of Medicine, and 4DMedical recently announced the creation of the Functional Lung Imaging Research Program in the Department of Medicine’s Division of Pulmonary, Critical Care and Sleep Medicine at the Miller School. 4DMedical is an Australian medical technology company and the developer of XV Technology, a four-dimensional lung imaging technology.
The Functional Lung Imaging Research Program, 4DMedical’s first research program in a U.S. health system, will use its breakthrough imaging technology to improve treatment outcomes for patients with chronic lung diseases. It will define the physiological impact of numerous lung-related conditions such as emphysema, cystic fibrosis, pulmonary hypertension, pulmonary embolism, and lung cancer on respiratory function to improve diagnostic approaches and management strategies for patients.
“We look forward to using this new imaging development,” said Naresh M. Punjabi, M.D., Ph.D., chief of the Division of Pulmonary, Critical Care and Sleep Medicine at the Miller School of Medicine. “The fully functional lung imaging capability provided by 4DMedical will be used to achieve deeper insights into disease pathophysiology and help pave the development of new diagnostic and therapeutic solutions.”
